“`html
Summary of Clinical Trial Report
Background
Neovascular age-related macular degeneration (nAMD) treatments require long-term follow-up of disease activity, which can be burdensome for patients and caregivers. Home-monitoring could alleviate this burden and free up clinic capacity.
Objective
The study aimed to assess the effectiveness of 3 vision home-monitoring tests in detecting active nAMD compared to traditional hospital follow-up for monitoring disease activity after treatment.
Methods
- Diagnostic test accuracy study with 297 patients from 6 UK hospital eye clinics
- Participants aged 50 years and older with at least 1 eye treated for active nAMD
- Evaluated home-monitoring tests: KeepSight Journal (KSJ), MyVisionTrack (mVT), and MultiBit (MBT)
- Raw scores between hospital follow-ups were averaged
Findings
Results showed that none of the home-monitoring tests provided satisfactory accuracy in identifying active nAMD diagnosed during hospital follow-up. Only the KSJ summary score was associated with lesion activity.
Implications
Implementing these home-monitoring tests with ophthalmologists only reviewing positive results could lead to missing most active lesions and risking unnecessary sight loss.
Conclusion
The study suggests that the evaluated home-monitoring vision tests may not be reliable for identifying active nAMD. Further research and development of alternative monitoring solutions may be necessary.
“`
